Home › Prostate Cancer › Alabama
Prostate Cancer clinical trials in Alabama
13 studies for Prostate Cancer are looking for participants at sites in Alabama.
Cities in Alabama
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03866382Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- University of Alabama at Birmingham, Birmingham
Recruiting
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT06511141Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- University of Alabama at Birmingham Cancer Center, Birmingham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06632977Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Alabama at Birmingham Hospital, Birmingham
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Oct 29, 2026 · NCT05519449Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- University of Alabama at Birmingham Cancer Center, Birmingham
- The Kirklin Clinic at Acton Road, Birmingham
- Lewis and Faye Manderson Cancer Center, Tuscaloosa
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 23, 2026 · NCT05946213AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Dothan
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 19, 2026 · NCT07611110Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Urology Centers Of Alabama Pc, Homewood
RecruitingPhase 3
Ages 18 to 100 · Men · Updated Oct 15, 2026 · NCT06855277This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Clearview Cancer Institute (Crestwood), Huntsville
- Clearview Cancer Institute, Huntsville
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 14, 2026 · NCT07028853DESTINY-PANTUMOUR04
- Research Site, Birmingham
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- University of Alabama Birmingham Hospital, Birmingham
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2026 · NCT06056830A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Clearview Cancer Institute, Huntsville
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 3, 2026 · NCT07005154International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of Alabama- Tuscaloosa, Tuscaloosa
RecruitingObservational study
Ages 21 and older · Men · Updated May 22, 2026 · NCT03151629SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.